METLIFE INC

METLIFE INC (MET) — Investment Memo

🐂 The Bull Case (Warren's voice)

We aren't buying a growth story; we are buying a float machine.

• The Power of the Float: MetLife is a master of the "float" game. They collect premiums upfront and hold the capital for decades. If they can underwrite with even a slight edge, the compounding effect of that capital is a massive tailwind.
• Regulatory Fortress: This is a "barrier to entry" play. The capital requirements and regulatory red tape required to compete at this scale act as a natural moat. New competitors cannot simply appear; they must build decades of reserves.
• Global Diversification: Exposure to Asia and Latin America provides a hedge. They aren't just betting on the US economy; they are betting on the global rise of the middle class and their need for retirement security.
• Attractive Entry: If the business can be stripped of its "accounting noise" and treated as a steady stream of cash, it becomes an attractive utility.
• Price for Interest: This becomes a Berkshire-grade asset if it trades at a significant discount to book value, allowing us to buy the float and the assets at a fraction of their replacement cost.

🐻 The Bear Case (Charlie inverts)

"Show me where I'll die and I won't go there."

• The Accounting Hallucination: Net income is a fairy tale here. When profits swing from $0.8B to $6.9B, you aren't looking at a business; you're looking at a casino where the house is guessing the rules. If the FCF is missing, the "earnings" are just ink on a page.
• Structural Obsolescence: The shift from Defined Benefit (company-funded) to Defined Contribution (employee-funded) plans is a permanent erosion of their core moat. They are fighting for a shrinking piece of a legacy pie.
• The "Complexity" Trap: PineBridge and the various global subsidiaries create a "fog of war." Complexity is where management hides mediocrity and where catastrophic risks (like longevity miscalculations) go unnoticed until it's too late.
• The Most Likely Killer: Longevity Risk. If people live just 2–3 years longer than the actuarial tables predict, the liabilities explode while the assets remain static. This isn't a "recession" risk; it's a mathematical death sentence.

💰 Valuation & Margin of Safety

The DCF tells us the business is a commodity; the price must reflect that.

• Intrinsic value estimate: $65.88 per share
• 25% margin of safety entry: $49.41 (conservative)
• 50% margin of safety entry: $32.94 (Buffett's ideal)
• Current Status: Based on the DCF, the stock is overvalued. We are being asked to pay for "growth" (2.3% FCF) that the business model is structurally struggling to deliver.

Verdict: PASS

The intrinsic value of $65.88 provides no cushion against the "mood swing" earnings and structural decay. The moat is merely a result of size, not a competitive advantage in pricing or product. We do not buy complexity masquerading as stability.